第57回日本動脈硬化学会総会・学術集会(The 57th Annual Scientific Meeting of the Japan Atherosclerosis Society)

FH Summit Japan 2025

Familial Hypercholesterolemia (FH) Summit Japan 2025
Satellite Symposium of the 57th Annual Meeting of the Japan Atherosclerosis Society

Date & Time:
Friday, July 4, 2025 9:55 AM – 3:45 PM
Venue:
Tsukuba International Congress Center Room201 https://www.epochal.or.jp/en/
Participation:
Free of Charge

Join leading experts at FH Summit Japan 2025 — complete your registration here!

Opening Remarks

09:55 – 10:00

Hayato Tada (Kanazawa University)
Vice Chairperson, Familial Hypercholesterolemia Committee, Japan Atherosclerosis Society

Intractable FH (Intractable FH Study Group Session)

10:00 – 11:00

Chairperson:
Hiroaki Okazaki (Jichi Medical University)
Speakers:

Homozygous familial hypercholesterolaemia in South Africa – advances in treatment

Frederick J. Raal (University of the Witwatersrand)

Challenges in the Diagnosis and Treatment of HoFH in Japan

Atsushi Nohara (Ishikawa Prefectural Central Hospital)

Identification of Very High-risk Japanese FH Patients in the Primary Prevention Settings

Yu Kataoka (National Cerebral and Cardiovascular Center)

FH Diagnosis and Treatment in East Asia (JAS-KSoLA Joint Symposium)

11:00 – 12:00

Chairperson:
Kenichi Tsujita (Kumamoto University)
Speakers:

Genetic Approaches to FH Management: Clinical Implementation and Insurance Coverage in Japan

Masayuki Yoshida (Institute of Science Tokyo)

Challenges in the Diagnosis and Management of Familial Hypercholesterolemia in South Korea

Chan Joo Lee (Yonsei University)

Achilles Tendon Ultrasonography for Diagnosing Familial Hypercholesterolemia and Assessing Risk of Coronary Artery Disease

Masahito Michikura (Osaka Medical and Pharmaceutical University)

FH Academy Seminar [Luncheon Seminar]

12:10 – 13:00

Chairperson:
Masaaki Kawashiri (Kaga Medical Center)
Speakers:

FH Academy 2024: A Summary Report

Masatsune Ogura (Juntendo University)

The Role of a Specialist within a Generalist Framework: ~A Focus on Lipid Disorder in ‘‘FH Academy”~

Kenta Mori (Toyooka Hospital)

FH Research by Young Researchers

13:10 – 14:10

Chairperson:
Daisaku Masuda (Rinku General Medical Center)
Speakers:

Lipoprotein(a) in Familial Hypercholesterolemia

Hwi Seung Kim (Chung-Ang University)

Evaluation of Achilles Tendon Thickness by Ultrasonography in Familial Hypercholesterolemia Diagnosed through Pediatric Universal Screening in Kagawa

Tomoko Inoue (Kagawa University)

Serum Proteomic Profiling Using Data-Independent Acquisition Mass Spectrometry for Familial Hypercholesterolemia: A Comparative Study in a Korean Population

Dae Young Cheon (Hallym University)

Prognostic Value of Achilles Tendon Assessment by Echography to Predict Complexity of Coronary Artery Disease in Non-Familial Hypercholesterolemia Patients with Acute Coronary Syndrome

Shimpei Fujioka (Osaka Medical and Pharmaceutical University)

HoFH [Sponsored Session]

14:20 – 15:40

Chairpersons:
Mariko Harada-Shiba (Osaka Medical and Pharmaceutical University)
Chairpersons:
Frederick J. Raal (University of the Witwatersrand)
Speakers:

Updated Approaches to Pediatric HoFH: From Diagnosis to LDLR-Independent Therapies

Yukiyo Yamamoto (University of Occupational and Environmental Health)

Diagnosis and Treatment for Adult HoFH Patients in Japan

Hayato Tada(Kanazawa University)

Characteristics of Atherosclerosis in HoFH

Yu Kataoka (National Cerebral and Cardiovascular Center)

Reinforcing LDL-C as the Central Target in Contemporary ASCVD Care: Why Deeper Lowering Matters Now

Hiroshi Iwata (Juntendo University)

Closing Remarks

15:40 – 15:45

Mariko Harada-Shiba (Osaka Medical and Pharmaceutical University)
Chairperson, Familial Hypercholesterolemia Committee, Japan Atherosclerosis Society